Polymorphisms in Maternal Selected Folate Metabolism-Related Genes in Neural Tube Defect-Affected Pregnancy

[1]  Ji Li,et al.  MTRR rs1532268 polymorphism and gastric cancer risk: evidence from a meta-analysis , 2022, The Journal of international medical research.

[2]  D. Feng,et al.  Association of MTHFR 677C > T gene polymorphism with neonatal defects: a meta-analysis of 81444 subjects , 2022, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[3]  T. Matsha,et al.  Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks , 2021, Nutrients.

[4]  B. Wlodarczyk,et al.  Gene Environment Interactions in the Etiology of Neural Tube Defects , 2021, Frontiers in Genetics.

[5]  Everton Cruz dos Santos,et al.  MTHFR C677T and A1298C Polymorphisms in Breast Cancer, Gliomas and Gastric Cancer: A Review , 2021, Genes.

[6]  K. Nasri,et al.  Association of MTHFR C677T, MTHFR A1298C, and MTRR A66G Polymorphisms with Neural Tube Defects in Tunisian Parents , 2019, Pathobiology.

[7]  Wei Liu,et al.  Association of neural tube defects with maternal alterations and genetic polymorphisms in one-carbon metabolic pathway , 2019, Italian Journal of Pediatrics.

[8]  Yuying Wang,et al.  Two Common MTHFR Gene Polymorphisms (C677T and A1298C) and Fetal Congenital Heart Disease Risk: An Updated Meta-Analysis with Trial Sequential Analysis , 2018, Cellular Physiology and Biochemistry.

[9]  K. Kamali,et al.  The study of association between reduced folate carrier 1 (RFC1) polymorphism and non-syndromic cleft lip/palate in Iranian population , 2017, BioImpacts : BI.

[10]  A. Oussalah,et al.  Association of TCN2 rs1801198 c.776G>C polymorphism with markers of one-carbon metabolism and related diseases: a systematic review and meta-analysis of genetic association studies. , 2017, The American journal of clinical nutrition.

[11]  H. Ghazy,et al.  MTHFR A1298C and C677T gene polymorphisms and susceptibility to chronic myeloid leukemia in Egypt. , 2014, International journal of clinical and experimental pathology.

[12]  Yuan-yuan Li,et al.  Association between MTR A2756G and MTRR A66G polymorphisms and maternal risk for neural tube defects: a meta-analysis. , 2013, Gene.

[13]  Jian Zhang,et al.  Reduced folate carrier A80G polymorphism and susceptibility to neural tube defects: a meta-analysis. , 2012, Gene.

[14]  G. Chandak,et al.  Maternal one-carbon metabolism, MTHFR and TCN2 genotypes and neural tube defects in India. , 2011, Birth defects research. Part A, Clinical and molecular teratology.

[15]  J. Yarnell,et al.  The transcobalamin (TCN2) 776C>G polymorphism affects homocysteine concentrations among subjects with low vitamin B12 status , 2010, European Journal of Clinical Nutrition.

[16]  E. Van Obberghen,et al.  Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: A multicenter case–control study , 2008, American journal of medical genetics. Part A.

[17]  A. Parle‐McDermott,et al.  Reduced folate carrier polymorphisms and neural tube defect risk. , 2006, Molecular genetics and metabolism.

[18]  M. Margaglione,et al.  Homocysteine metabolism in families from southern Italy with neural tube defects: role of genetic and nutritional determinants , 2006, Prenatal diagnosis.

[19]  M. Alikaşifoğlu,et al.  Analysis of MTHFR 1298A>C in addition to MTHFR 677C>T polymorphism as a risk factor for neural tube defects in the Turkish population. , 2005, The Turkish journal of pediatrics.

[20]  A. Parle‐McDermott,et al.  Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. , 2005, Molecular genetics and metabolism.

[21]  M. Marazita,et al.  Studies of reduced folate carrier 1 (RFC1) A80G and 5,10‐methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms with neural tube and orofacial cleft defects , 2005, American journal of medical genetics. Part A.

[22]  A. Parle‐McDermott,et al.  Evaluation of transcobalamin II polymorphisms as neural tube defect risk factors in an Irish population. , 2005, Birth defects research. Part A, Clinical and molecular teratology.

[23]  G. Kauwell,et al.  Methionine synthase reductase 66A->G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C->T variant. , 2004, The Journal of nutrition.

[24]  T. Félix,et al.  Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil. , 2004, Birth defects research. Part A, Clinical and molecular teratology.

[25]  M. Pearce,et al.  Gene–gene interaction in folate-related genes and risk of neural tube defects in a UK population , 2004, Journal of Medical Genetics.

[26]  P. Ueland,et al.  High-level multiplex genotyping of polymorphisms involved in folate or homocysteine metabolism by matrix-assisted laser desorption/ionization mass spectrometry. , 2004, Clinical chemistry.

[27]  A. Parle‐McDermott,et al.  Analysis of the MTHFR 1298A→C and 677C→T polymorphisms as risk factors for neural tube defects , 2003, Journal of Human Genetics.

[28]  H. Blom,et al.  Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects , 2002, European Journal of Human Genetics.

[29]  R. Finnell,et al.  Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population , 2002, Journal of Human Genetics.

[30]  A. Evans,et al.  The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. , 2001, Atherosclerosis.

[31]  J H Eckfeldt,et al.  The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. , 2001, Atherosclerosis.

[32]  K. Volcik,et al.  Methylenetetrahydrofolate reductase and spina bifida: evaluation of level of defect and maternal genotypic risk in Hispanics. , 2000, American journal of medical genetics.

[33]  J. Kaufman,et al.  A Common Polymorphism in Methionine Synthase Reductase Increases Risk of Premature Coronary Artery Disease , 2000, Journal of cardiovascular risk.

[34]  R. Rozen,et al.  A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. , 1999, Molecular genetics and metabolism.

[35]  D. Shields,et al.  The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. , 1999, American journal of human genetics.

[36]  R. Rozen.  Genetic Predisposition to Hyperhomocysteinemia: Deficiency of Methylenetetrahydrofolate Reductase (MTHFR) , 1997, Thrombosis and Haemostasis.

[37]  L. Matherly,et al.  Biology of the major facilitative folate transporters SLC19A1 and SLC46A1. , 2014, Current topics in membranes.

[38]  Wan-I Li,et al.  Correlation of polymorphism of MTHFRs and RFC-1 genes with neural tube defects in China. , 2008, Birth defects research. Part A, Clinical and molecular teratology.